Drug Availability

HPS Pharmacies wish to give notice that Bayer and Apotex are experiencing a long-term supply interruption for moxifloxacin tablets as follows:

Avelox® Tablets
Moxifloxacin (as hydrochloride) 400mg
ARTG 75766

Moxifloxacin Apotex Tablets
Moxifloxacin (as hydrochloride) 400mg
ARTG 223564

An internationally registered brand of moxifloxacin 400mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that this alternative is subject to a longer lead time as it must be sourced internationally.

Moxifloxacin is a quinolone antibiotic that should only be considered for the treatment of proven or suspected infections where alternative agents are ineffective or contraindicated. In the treatment of pneumonia, it should be reserved for patients with immediate hypersensitivity to penicillins. Specialist advice from an Infectious Diseases physician is recommended when considering alternative antibiotics for individual patients.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates